Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
The heath secretary, Dr. Rachel Levine, announced Thursday she’ll be adding them as of July 20. Levine says her decision was based on the recommendation of the state’s Medical Marijuana Advisory Board and her own review of medical research literature. She says medical marijuana shouldn’t be the first treatments for those conditions, but physicians can recommend it to be used together with traditional therapeutic approaches. The list already includes cancer, epilepsy, intractable seizures, post-traumatic stress disorder, terminal illness and other conditions. Nearly 111,000 Pennsylvanians have been certified for participation in the state’s medical marijuana program .

Ex Output:
State adds anxiety to qualifying conditions for medical pot.


Ex Input:
"A bipartisan push in Albany would classify offenses against first responders and law enforcement officers as hate crimes. The Community Heroes Protection Act would also toughen the sentences for those convicted. State Sen. Martin J. Golden, a Republican from Brooklyn and co-sponsor of the bill, said the number of assaults on police officers in New York state should convince his colleagues to support the effort. ""The numbers show this law is definitely needed,"" Golden said. ""Just last year, alone, 710 police officers - this is just police officers - were assaulted in this state."" Is Golden right? Were that many police officers assaulted last year? Data from the FBI The Federal Bureau of Investigation has reported the number of law enforcement officers killed and assaulted in the United States since 1972. The FBI defines a law enforcement officer as a local, state, and federal public authority who ordinarily carries a badge and a firearm. The report does not include attacks on correctional officers or emergency responders, though they are included in the proposed legislation. The bureau reported 710 assaults on New York state law enforcement officers in 2015, the latest data available. That’s the lowest number since 2007, when 656 officers were assaulted. The FBI's New York state number, however, is not a statewide figure. It only includes assaults on law enforcement officers outside New York City. The agency said it does not have data for reported assaults on law enforcement officers in New York City. Data from the NYPD The New York City Police Department reports its own data on police assaults, but it defines officers more broadly. The Police Department tracks assaults on police officers, peace officers, prosecutors, nurses, sanitation workers, firefighters, paramedics, city marshals, school crossing guards, traffic agents and emergency responders. The department said it does not report solely the number of assaults on law enforcement officers. Last year the department reported 1,632  assaults on people within the department's definition. That’s down from 2015, when 1,738 assaults were reported. Our ruling Golden said,  ""Just last year alone, 710 police officers … were assaulted in this state."" Golden relied on FBI data that does not include assaults on officers from New York City. Golden undercounted, but his point is not lost: The number of reported assaults on law enforcement officers is significant. His statement needs clarification and additional information.

Ex Output:
"Just last year, alone, 710 police officers"" were assaulted in New York state."


Ex Input:
The story includes a tentative estimate of what this sort of blood test might cost if it is approved. It would be difficult for readers to get a true sense of the value of this test from this story. Readers should have been told more clearly that in this study, the test failed to correctly identify 4 percent of the Alzheimer’s patients and it mislabeled more than 7 percent of the healthy participants. Also, the phrase that “knowing early has many advantages” is likely to create a misperception about the potential benefits of testing – at least until some treatments are developed. The story mentioned only two potential benefits, financial planning and the ability to participate in clinical trials of experimental treatments. The story does not discuss the potential harms of this sort of test. As mentioned above, some healthy people would be told in error that they have signs of Alzheimer’s Disease. Such a misdiagnosis could have profoundly grave consequences. Although the story does include the results reported by the researchers, notes the small number of individuals in the study, and points out the preliminary nature of this work; it falls short. Although the headline proclaims “   Blood Test May Spot Alzheimer’s Before Symptoms Appear,” as the story points out lower down, the researchers have not yet studied people over time, so they cannot make any claims about predictive power. And, indeed, that’s really what people want to know, whether someone with some memory problems is going to progress to Alzheimer’s Disease, something that these researchers have yet to investigate. Then the lead sentence states the test is 96 percent “accurate,” which is not the full story. The researchers reported that this blood test correctly identified 96 percent of Alzheimer’s patients and 92.5 percent of healthy people. The story would have been better if it had pointed out that the second number means that as things stand, for every 100 healthy people tested, seven or eight would be misdiagnosed as having signs of Alzheimer’s, a frightening result for those individuals. The story does not exaggerate the extent or severity of Alzheimer’s Disease. However, it might have been helpful to include some description of the sort of individual who might consider using this sort of test. Stories like this need to be clear that since there is no meaningful treatment currently available for Alzheimer’s disease, many individuals may not want to be burdened with the prospect of impending dementia when there is no known way to do anything about it. The story would have been better if rather than focusing on individuals and the fearful prospect of Alzheimer’s, it had given more attention to the most likely near-term use for Alzheimer’s tests: as aids to researchers studying potential treatments in controlled trials. The story includes a spokesperson from the Alzheimer’s Association. It does not appear that this group was involved with this study. We would have preferred hearing from an independent scientist rather than someone from an advocacy group. Nonetheless the Association spokesman adds some important perspectives. The story does point out near the top that the lead researcher is the founder of the company developing the test. A strength of this story is that it prominently points out that many other potential tests for Alzheimer’s Disease are being developed. The story would have been better if it had explained why some people might choose not to be tested. Deep in the story, it explains that “if all goes well” the developer is hopeful the test could be available within a year. That is followed by an Alzheimer’s Association spokesman saying this is “preliminary.”  So the developer’s optimism is tempered somewhat. This rating is a close call. The story does include comments pointing out that there are a number of other tests for Alzheimer’s Disease being developed, but it might have been better to frame the headline and lead in a way that immediately makes clear to readers where this test fits in the context of other research. The lead could have used a phrase such as “one more potential test for Alzheimer’s enters the pipeline.” The story includes interview quotes and does not appear to rely on a news release.

Ex Output:

Blood Test May Spot Alzheimer’s Before Symptoms Appear